Banque Cantonale Vaudoise Boosts Stock Holdings in Astera Labs, Inc. $ALAB

by · The Markets Daily

Banque Cantonale Vaudoise increased its stake in Astera Labs, Inc. (NASDAQ:ALAB – Free Report) by 85.9% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 6,990 shares of the company’s stock after acquiring an additional 3,229 shares during the period. Banque Cantonale Vaudoise’s holdings in Astera Labs were worth $766,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the stock. Lido Advisors LLC grew its stake in Astera Labs by 0.5% during the 4th quarter. Lido Advisors LLC now owns 12,297 shares of the company’s stock worth $2,046,000 after purchasing an additional 57 shares in the last quarter. Perigon Wealth Management LLC boosted its stake in shares of Astera Labs by 6.2% in the 4th quarter. Perigon Wealth Management LLC now owns 1,252 shares of the company’s stock valued at $208,000 after buying an additional 73 shares during the period. Clearstead Advisors LLC boosted its stake in shares of Astera Labs by 13.6% in the 3rd quarter. Clearstead Advisors LLC now owns 636 shares of the company’s stock valued at $125,000 after buying an additional 76 shares during the period. Sound Income Strategies LLC grew its position in shares of Astera Labs by 9.2% during the fourth quarter. Sound Income Strategies LLC now owns 902 shares of the company’s stock worth $164,000 after buying an additional 76 shares in the last quarter. Finally, Venturi Wealth Management LLC grew its position in shares of Astera Labs by 2.6% during the fourth quarter. Venturi Wealth Management LLC now owns 3,284 shares of the company’s stock worth $546,000 after buying an additional 84 shares in the last quarter. 60.47% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

ALAB has been the subject of several analyst reports. Jefferies Financial Group reiterated a “buy” rating and set a $270.00 price target on shares of Astera Labs in a report on Wednesday, May 6th. Royal Bank Of Canada raised their price objective on shares of Astera Labs from $250.00 to $270.00 and gave the company an “outperform” rating in a report on Wednesday, May 6th. Citigroup cut shares of Astera Labs from a “buy” rating to a “market perform” rating in a research report on Tuesday, May 26th. Needham & Company LLC boosted their target price on shares of Astera Labs from $220.00 to $260.00 and gave the stock a “buy” rating in a research note on Wednesday, May 6th. Finally, TD Cowen raised their price target on Astera Labs from $140.00 to $225.00 and gave the company a “hold” rating in a research note on Wednesday, May 6th. Twelve analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the stock. According to MarketBeat.com, Astera Labs presently has an average rating of “Moderate Buy” and an average target price of $254.75.

Read Our Latest Research Report on Astera Labs

Astera Labs Trading Down 1.6%

ALAB stock opened at $391.74 on Friday. The stock has a market cap of $67.15 billion, a P/E ratio of 264.69, a PEG ratio of 4.50 and a beta of 3.95. Astera Labs, Inc. has a twelve month low of $85.85 and a twelve month high of $440.99. The company’s 50 day moving average is $289.20 and its two-hundred day moving average is $196.09.

Astera Labs (NASDAQ:ALAB – Get Free Report) last issued its earnings results on Tuesday, May 5th. The company reported $0.61 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.54 by $0.07. The business had revenue of $308.36 million during the quarter, compared to analysts’ expectations of $292.19 million. Astera Labs had a net margin of 26.72% and a return on equity of 18.49%. The company’s revenue for the quarter was up 93.5% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.33 EPS. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. On average, equities research analysts predict that Astera Labs, Inc. will post 1.84 earnings per share for the current year.

Insider Transactions at Astera Labs

In other news, General Counsel Philip Mazzara sold 796 shares of Astera Labs stock in a transaction dated Thursday, May 21st. The stock was sold at an average price of $291.03, for a total transaction of $231,659.88. Following the sale, the general counsel owned 103,343 shares in the company, valued at approximately $30,075,913.29. The trade was a 0.76% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Bethany Mayer sold 686 shares of the business’s stock in a transaction dated Wednesday, June 24th. The shares were sold at an average price of $395.04, for a total value of $270,997.44. Following the completion of the sale, the director directly owned 5,550 shares of the company’s stock, valued at $2,192,472. The trade was a 11.00% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 2,161,942 shares of company stock valued at $460,115,294 over the last quarter. 10.40% of the stock is owned by corporate insiders.

Astera Labs Company Profile

(Free Report)

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.

Further Reading

Want to see what other hedge funds are holding ALAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astera Labs, Inc. (NASDAQ:ALAB – Free Report).